Cargando…
A prospective interventional study to evaluate the effects of medical therapy (Mifepristone 25 mg) on the management of uterine fibroids
BACKGROUND AND OBJECTIVES: In India, the uterine fibroid is a common indication of hysterectomy. An effective option for medical treatment may decrease the morbidity associated with hysterectomy. We aimed to evaluate the effect of mifepristone (25 mg), progesterone antagonist, on uterine fibroids in...
Autores principales: | Gupta, Meeta, Jamwal, Narita, Sabharwal, Sumeet, Sobti, Shalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567249/ https://www.ncbi.nlm.nih.gov/pubmed/33102275 http://dx.doi.org/10.4103/jfmpc.jfmpc_467_20 |
Ejemplares similares
-
Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
por: Seth, Shikha, et al.
Publicado: (2013) -
Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017) -
Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery
por: Carbonell Esteve, Josep L, et al.
Publicado: (2012) -
Safety and effectiveness of different dosage of mifepristone for the treatment of uterine fibroids: a double-blind randomized clinical trial
por: Carbonell, Josep LL, et al.
Publicado: (2013) -
Low dose Mifepristone (100 mg) for medical termination of pregnancy
por: Seth, Shikha, et al.
Publicado: (2011)